Mark William Lowdell
Insider Reports History
- Location
- Beaumont
- Signature
- /s/ Mark William Lowdell
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Mark William Lowdell:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inmune Bio, Inc. | Chief Scientific Officer | Option (right to buy) | 600,000 | 01 Dec 2025 | Direct | ||
| Inmune Bio, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 100,000 | 18 Nov 2025 | Direct |
Insider Reports Filed by Mark William Lowdell
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| INMB | Inmune Bio, Inc. | 01 Dec 2025 | 1 | $0 | 4 | Chief Scientific Officer | 02 Dec 2025, 16:43 |
| INMB | Inmune Bio, Inc. | 18 Nov 2025 | 10 | $0 | 4 | Chief Scientific Officer | 18 Nov 2025, 17:29 |
| INMB | Inmune Bio, Inc. | 05 Dec 2024 | 1 | $0 | 4 | Chief Scientific Officer, 10%+ Owner | 09 Dec 2024, 16:00 |
| INMB | Inmune Bio, Inc. | 14 May 2024 | 1 | $0 | 4 | Chief Scientific Officer, 10%+ Owner | 16 May 2024, 16:08 |
| INMB | Inmune Bio, Inc. | 19 Apr 2024 | 2 | +$121,802 | 4/A | Chief Scientific Officer, 10%+ Owner | 24 Apr 2024, 14:08 |
| INMB | Inmune Bio, Inc. | 19 Apr 2024 | 2 | +$121,802 | 4 | Chief Scientific Officer, 10%+ Owner | 23 Apr 2024, 17:54 |
| INMB | Inmune Bio, Inc. | 21 Mar 2022 | 2 | +$198,864 | 4 | Chief Scientific Officer, 10%+ Owner | 23 Mar 2022, 16:35 |
| INMB | Inmune Bio, Inc. | 03 Nov 2021 | 1 | -$14,020 | 4 | Chief Scientific Officer, 10%+ Owner | 04 Nov 2021, 16:00 |
| INMB | Inmune Bio, Inc. | 27 Oct 2021 | 1 | -$47,140 | 4 | Chief Scientific Officer, 10%+ Owner | 29 Oct 2021, 16:03 |
| INMB | Inmune Bio, Inc. | 22 Oct 2021 | 1 | -$8,000 | 4 | Chief Scientific Officer, 10%+ Owner | 26 Oct 2021, 16:31 |
| INMB | Inmune Bio, Inc. | 07 Jul 2021 | 2 | -$604,706 | 4 | Chief Scientific Officer | 09 Jul 2021, 16:06 |